US equity
·Updated Aug 26, 21:38 UTCGILD
Gilead Sciences, Inc.
Health Care·Large cap·$184B
148.09
-0.5% today
No price history available for this name yet.
Returns & momentum
1D-0.5%
1W+0.3%
1M+10.3%
3M+11.5%
6M+1.9%
1Y+33.1%
YTD—
All-time—
Range & moving averages
Price148.09
52w high-4.7%
52w low+39.1%
All-time high—
All-time low—
% from ATH—
50-day MA—
vs 50-DMA—
200-day MA—
vs 200-DMA—
Liquidity & activity
Volume5.3M
Turnover$778M
Market cap$184B
RVOL0.80×
Risk & valuation
Real. vol 30d—
Real. vol 90d—
Max drawdown—
Beta · SPY—
P/E—
P/B—
ROE—
Div yield—
Financials
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29.4B | $28.8B | $27.1B | $27.3B | $27.3B | $24.7B | $22.4B | $22.1B | $26.1B | $30.4B | $32.6B | $24.9B | $11.2B | $9.7B | $8.4B | $7.9B |
| Cost of revenue | $6.2B | $6.3B | $6.5B | $5.7B | $6.6B | $4.6B | $4.7B | $4.9B | $4.4B | $4.3B | — | — | — | — | — | — |
| Research & development | — | — | — | — | — | — | $9.1B | $5.0B | $3.7B | $5.1B | $3.0B | $2.9B | $2.1B | $1.8B | $1.2B | — |
| Selling, general & admin | $5.8B | $6.1B | $6.1B | $5.7B | $5.2B | $5.2B | $4.4B | $4.1B | $3.9B | $3.4B | $3.4B | $3.0B | $1.7B | $1.5B | $1.2B | $1.0B |
| Operating income | $10.0B | $1.7B | $7.6B | $7.3B | $9.9B | $4.1B | $4.3B | $8.2B | $14.1B | $17.6B | $22.2B | $15.3B | $4.5B | $4.0B | $3.8B | $4.0B |
| Interest expense | — | — | $944M | $935M | $1.0B | $984M | $995M | $1.1B | $1.1B | $964M | $688M | $412M | $307M | $361M | $205M | $109M |
| Income tax | $1.3B | $211M | $1.2B | $1.2B | $2.1B | $1.6B | -$204M | $2.3B | $8.9B | $3.6B | $3.6B | $2.8B | $1.2B | $1.0B | $862M | $1.0B |
| Net income | $8.5B | $480M | $5.7B | $4.6B | $6.2B | $123M | $5.4B | $5.5B | $4.6B | $13.5B | $18.1B | $12.1B | $3.1B | $2.6B | $2.8B | $2.9B |
| EPS — basic | $6.84 | $0.38 | $4.54 | $3.66 | $4.96 | $0.10 | $4.24 | $4.20 | $3.54 | $10.08 | $12.37 | $7.95 | $2.01 | $1.71 | $1.81 | $1.69 |
| EPS — diluted | $6.78 | $0.38 | $4.50 | $3.64 | $4.93 | $0.10 | $4.22 | $4.17 | $3.51 | $9.94 | $11.91 | $7.35 | $1.81 | $1.64 | $1.77 | $1.66 |
| Shares — basic | 1.24B | 1.25B | 1.25B | 1.26B | 1.26B | 1.26B | 1.27B | 1.3B | 1.31B | 1.34B | 1.46B | 1.52B | 1.53B | 1.52B | 1.55B | 1.71B |
| Shares — diluted | 1.26B | 1.26B | 1.26B | 1.26B | 1.26B | 1.26B | 1.28B | 1.31B | 1.32B | 1.36B | 1.52B | 1.65B | 1.7B | 1.58B | 1.58B | 1.75B |
From SEC filings (public domain), since 2008. Values as reported (USD); per-share figures are per diluted/basic share. Point-in-time — each figure reflects the latest amount filed for that period. Descriptive context only, not advice.
Informational scan, not a buy/sell recommendation or financial advice in any jurisdiction.